These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24889417)

  • 1. Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.
    Brener L; Horwitz R; von Hippel C; Bryant J; Treloar C
    Psychol Health Med; 2015; 20(2):148-53. PubMed ID: 24889417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
    Treloar C; Rance J; Grebely J; Dore GJ
    Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenging stereotypes and changing attitudes: Improving quality of care for people with hepatitis C through Positive Speakers programs.
    Brener L; Wilson H; Rose G; Mackenzie A; de Wit J
    Psychol Health Med; 2013; 18(2):242-9. PubMed ID: 22783938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs.
    Broady TR; Valerio H; Alavi M; Wheeler A; Silk D; Martinello M; Conway A; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Treloar C; Grebely J;
    Int J Drug Policy; 2024 Jun; 128():104468. PubMed ID: 38795465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of diagnosis, care and treatment among Aboriginal people living with hepatitis C.
    Brener L; Wilson H; Jackson LC; Johnson P; Saunders V; Treloar C
    Aust N Z J Public Health; 2016 Apr; 40 Suppl 1():S59-64. PubMed ID: 26123616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health workers' support for hepatitis C treatment uptake among clients with a history of injecting.
    Brener L; von Hippel C; Wilson H; Hopwood M
    J Health Psychol; 2018 Jul; 23(8):1012-1018. PubMed ID: 27098384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study.
    Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C
    Int J Drug Policy; 2024 Jul; 129():104477. PubMed ID: 38861842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
    Day C; Ross J; Dolan K
    Drug Alcohol Rev; 2003 Sep; 22(3):317-21. PubMed ID: 15385226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "It gives me a sense of belonging": providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group.
    Woolhouse S; Cooper E; Pickard A
    Int J Drug Policy; 2013 Nov; 24(6):550-7. PubMed ID: 23860471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion.
    Deacon RM; Mooney-Somers J; Treloar C; Maher L
    Health Soc Care Community; 2013 Jul; 21(4):402-10. PubMed ID: 23465052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation.
    Rose G; Cama E; Brener L; Treloar C
    Aust Health Rev; 2013 Nov; 37(5):654-9. PubMed ID: 24160716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discrimination perceived by people with a diagnosis of schizophrenic disorders. INternational study of DIscrimination and stiGma Outcomes (INDIGO): French results].
    Daumerie N; Vasseur Bacle S; Giordana JY; Bourdais Mannone C; Caria A; Roelandt JL
    Encephale; 2012 Jun; 38(3):224-31. PubMed ID: 22726410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
    Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?
    Brener L; von Hippel W; Kippax S
    Int J Drug Policy; 2007 Oct; 18(5):381-7. PubMed ID: 17854726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia.
    Keats J; Micallef M; Grebely J; Hazelwood S; Everingham H; Shrestha N; Jones T; Bath N; Treloar C; Dore GJ; Dunlop A;
    Int J Drug Policy; 2015 Oct; 26(10):999-1006. PubMed ID: 26275578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.
    Treloar C; Rance J; Backmund M
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S51-5. PubMed ID: 23884066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive health beliefs and behaviours in the midst of difficult lives: women who inject drugs.
    Olsen A; Banwell C; Dance P; Maher L
    Int J Drug Policy; 2012 Jul; 23(4):312-8. PubMed ID: 22721571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
    Safo SA; Batchelder A; Peyser D; Litwin AH
    Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.